img

Global Sex Hormone Antagonist Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Sex Hormone Antagonist Market Insights, Forecast to 2034

A sex hormone antagonist is a drug that blocks the effects of sex hormones, such as testosterone, estrogen, and progesterone. Sex hormones play a role in many bodily functions, including sexual development, reproduction, and metabolism.
Market Analysis and InsightsGlobal Sex Hormone Antagonist Market
Global Sex Hormone Antagonist market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Sex Hormone Antagonist industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
The growth of the market is attributed to the increasing prevalence of hormone-related diseases, rising demand for effective treatments for hormone-related diseases, and growing awareness of the benefits of sex hormone antagonist therapy.
Here are some of the factors driving the growth of the sex hormone antagonist market
Increasing prevalence of hormone-related diseasesHormone-related diseases such as prostate cancer, breast cancer, and endometrial cancer are becoming more common. This is due to a number of factors, including aging population, changing lifestyles, and environmental factors.
Rising demand for effective treatments for hormone-related diseasesAs the prevalence of hormone-related diseases increases, so does the demand for effective treatments. Sex hormone antagonists are an important class of drugs that can be used to treat a variety of hormone-related diseases.
Growing awareness of the benefits of sex hormone antagonist therapyThe awareness of the benefits of sex hormone antagonist therapy is growing among both patients and healthcare professionals. This is leading to increased demand for sex hormone antagonist drugs.
The sex hormone antagonist market is expected to continue to grow in the coming years, driven by the factors mentioned above.
Report Covers
This report presents an overview of global Sex Hormone Antagonist market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Sex Hormone Antagonist market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Pfizer
Johnson & Johnson
AstraZeneca
Astellas
Merck
Sanofi
Eli Lilly and Company
Kyowa Kirin International
Bayer
Orion Corporation
Hengrui
Schering-Plough
Hinova Pharma
Jiangsu Hengrui Pharmaceuticals
Segment by Type
Antiestrogen
Antiprogestin
Antiandrogen

Segment by Application


Breast Cancer
Prostate Cancer
Endometriosis
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Sex Hormone Antagonist introduction, etc. Sex Hormone Antagonist Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Sex Hormone Antagonist
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sex Hormone Antagonist Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Antiestrogen
1.2.3 Antiprogestin
1.2.4 Antiandrogen
1.3 Market by Application
1.3.1 Global Sex Hormone Antagonist Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Breast Cancer
1.3.3 Prostate Cancer
1.3.4 Endometriosis
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sex Hormone Antagonist Market Perspective (2018-2033)
2.2 Global Sex Hormone Antagonist Growth Trends by Region
2.2.1 Sex Hormone Antagonist Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Sex Hormone Antagonist Historic Market Size by Region (2018-2023)
2.2.3 Sex Hormone Antagonist Forecasted Market Size by Region (2024-2033)
2.3 Sex Hormone Antagonist Market Dynamics
2.3.1 Sex Hormone Antagonist Industry Trends
2.3.2 Sex Hormone Antagonist Market Drivers
2.3.3 Sex Hormone Antagonist Market Challenges
2.3.4 Sex Hormone Antagonist Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Sex Hormone Antagonist by Players
3.1.1 Global Sex Hormone Antagonist Revenue by Players (2018-2023)
3.1.2 Global Sex Hormone Antagonist Revenue Market Share by Players (2018-2023)
3.2 Global Sex Hormone Antagonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Sex Hormone Antagonist, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Sex Hormone Antagonist Market Concentration Ratio
3.4.1 Global Sex Hormone Antagonist Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sex Hormone Antagonist Revenue in 2022
3.5 Global Key Players of Sex Hormone Antagonist Head office and Area Served
3.6 Global Key Players of Sex Hormone Antagonist, Product and Application
3.7 Global Key Players of Sex Hormone Antagonist, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Sex Hormone Antagonist Breakdown Data by Type
4.1 Global Sex Hormone Antagonist Historic Market Size by Type (2018-2023)
4.2 Global Sex Hormone Antagonist Forecasted Market Size by Type (2024-2033)
5 Sex Hormone Antagonist Breakdown Data by Application
5.1 Global Sex Hormone Antagonist Historic Market Size by Application (2018-2023)
5.2 Global Sex Hormone Antagonist Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Sex Hormone Antagonist Market Size (2018-2033)
6.2 North America Sex Hormone Antagonist Market Size by Type
6.2.1 North America Sex Hormone Antagonist Market Size by Type (2018-2023)
6.2.2 North America Sex Hormone Antagonist Market Size by Type (2024-2033)
6.2.3 North America Sex Hormone Antagonist Market Share by Type (2018-2033)
6.3 North America Sex Hormone Antagonist Market Size by Application
6.3.1 North America Sex Hormone Antagonist Market Size by Application (2018-2023)
6.3.2 North America Sex Hormone Antagonist Market Size by Application (2024-2033)
6.3.3 North America Sex Hormone Antagonist Market Share by Application (2018-2033)
6.4 North America Sex Hormone Antagonist Market Size by Country
6.4.1 North America Sex Hormone Antagonist Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Sex Hormone Antagonist Market Size by Country (2018-2023)
6.4.3 North America Sex Hormone Antagonist Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Sex Hormone Antagonist Market Size (2018-2033)
7.2 Europe Sex Hormone Antagonist Market Size by Type
7.2.1 Europe Sex Hormone Antagonist Market Size by Type (2018-2023)
7.2.2 Europe Sex Hormone Antagonist Market Size by Type (2024-2033)
7.2.3 Europe Sex Hormone Antagonist Market Share by Type (2018-2033)
7.3 Europe Sex Hormone Antagonist Market Size by Application
7.3.1 Europe Sex Hormone Antagonist Market Size by Application (2018-2023)
7.3.2 Europe Sex Hormone Antagonist Market Size by Application (2024-2033)
7.3.3 Europe Sex Hormone Antagonist Market Share by Application (2018-2033)
7.4 Europe Sex Hormone Antagonist Market Size by Country
7.4.1 Europe Sex Hormone Antagonist Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Sex Hormone Antagonist Market Size by Country (2018-2023)
7.4.3 Europe Sex Hormone Antagonist Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Sex Hormone Antagonist Market Size (2018-2033)
8.2 China Sex Hormone Antagonist Market Size by Type
8.2.1 China Sex Hormone Antagonist Market Size by Type (2018-2023)
8.2.2 China Sex Hormone Antagonist Market Size by Type (2024-2033)
8.2.3 China Sex Hormone Antagonist Market Share by Type (2018-2033)
8.3 China Sex Hormone Antagonist Market Size by Application
8.3.1 China Sex Hormone Antagonist Market Size by Application (2018-2023)
8.3.2 China Sex Hormone Antagonist Market Size by Application (2024-2033)
8.3.3 China Sex Hormone Antagonist Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Sex Hormone Antagonist Market Size (2018-2033)
9.2 Asia Sex Hormone Antagonist Market Size by Type
9.2.1 Asia Sex Hormone Antagonist Market Size by Type (2018-2023)
9.2.2 Asia Sex Hormone Antagonist Market Size by Type (2024-2033)
9.2.3 Asia Sex Hormone Antagonist Market Share by Type (2018-2033)
9.3 Asia Sex Hormone Antagonist Market Size by Application
9.3.1 Asia Sex Hormone Antagonist Market Size by Application (2018-2023)
9.3.2 Asia Sex Hormone Antagonist Market Size by Application (2024-2033)
9.3.3 Asia Sex Hormone Antagonist Market Share by Application (2018-2033)
9.4 Asia Sex Hormone Antagonist Market Size by Region
9.4.1 Asia Sex Hormone Antagonist Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Sex Hormone Antagonist Market Size by Region (2018-2023)
9.4.3 Asia Sex Hormone Antagonist Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Sex Hormone Antagonist Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Sex Hormone Antagonist Market Size by Type
10.2.1 Middle East, Africa, and Latin America Sex Hormone Antagonist Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Sex Hormone Antagonist Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Sex Hormone Antagonist Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Sex Hormone Antagonist Market Size by Application
10.3.1 Middle East, Africa, and Latin America Sex Hormone Antagonist Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Sex Hormone Antagonist Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Sex Hormone Antagonist Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Sex Hormone Antagonist Market Size by Country
10.4.1 Middle East, Africa, and Latin America Sex Hormone Antagonist Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Sex Hormone Antagonist Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Sex Hormone Antagonist Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Sex Hormone Antagonist Introduction
11.1.4 Pfizer Revenue in Sex Hormone Antagonist Business (2018-2023)
11.1.5 Pfizer Recent Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Sex Hormone Antagonist Introduction
11.2.4 Johnson & Johnson Revenue in Sex Hormone Antagonist Business (2018-2023)
11.2.5 Johnson & Johnson Recent Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Sex Hormone Antagonist Introduction
11.3.4 AstraZeneca Revenue in Sex Hormone Antagonist Business (2018-2023)
11.3.5 AstraZeneca Recent Developments
11.4 Astellas
11.4.1 Astellas Company Details
11.4.2 Astellas Business Overview
11.4.3 Astellas Sex Hormone Antagonist Introduction
11.4.4 Astellas Revenue in Sex Hormone Antagonist Business (2018-2023)
11.4.5 Astellas Recent Developments
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Sex Hormone Antagonist Introduction
11.5.4 Merck Revenue in Sex Hormone Antagonist Business (2018-2023)
11.5.5 Merck Recent Developments
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Sex Hormone Antagonist Introduction
11.6.4 Sanofi Revenue in Sex Hormone Antagonist Business (2018-2023)
11.6.5 Sanofi Recent Developments
11.7 Eli Lilly and Company
11.7.1 Eli Lilly and Company Company Details
11.7.2 Eli Lilly and Company Business Overview
11.7.3 Eli Lilly and Company Sex Hormone Antagonist Introduction
11.7.4 Eli Lilly and Company Revenue in Sex Hormone Antagonist Business (2018-2023)
11.7.5 Eli Lilly and Company Recent Developments
11.8 Kyowa Kirin International
11.8.1 Kyowa Kirin International Company Details
11.8.2 Kyowa Kirin International Business Overview
11.8.3 Kyowa Kirin International Sex Hormone Antagonist Introduction
11.8.4 Kyowa Kirin International Revenue in Sex Hormone Antagonist Business (2018-2023)
11.8.5 Kyowa Kirin International Recent Developments
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Bayer Business Overview
11.9.3 Bayer Sex Hormone Antagonist Introduction
11.9.4 Bayer Revenue in Sex Hormone Antagonist Business (2018-2023)
11.9.5 Bayer Recent Developments
11.10 Orion Corporation
11.10.1 Orion Corporation Company Details
11.10.2 Orion Corporation Business Overview
11.10.3 Orion Corporation Sex Hormone Antagonist Introduction
11.10.4 Orion Corporation Revenue in Sex Hormone Antagonist Business (2018-2023)
11.10.5 Orion Corporation Recent Developments
11.11 Hengrui
11.11.1 Hengrui Company Details
11.11.2 Hengrui Business Overview
11.11.3 Hengrui Sex Hormone Antagonist Introduction
11.11.4 Hengrui Revenue in Sex Hormone Antagonist Business (2018-2023)
11.11.5 Hengrui Recent Developments
11.12 Schering-Plough
11.12.1 Schering-Plough Company Details
11.12.2 Schering-Plough Business Overview
11.12.3 Schering-Plough Sex Hormone Antagonist Introduction
11.12.4 Schering-Plough Revenue in Sex Hormone Antagonist Business (2018-2023)
11.12.5 Schering-Plough Recent Developments
11.13 Hinova Pharma
11.13.1 Hinova Pharma Company Details
11.13.2 Hinova Pharma Business Overview
11.13.3 Hinova Pharma Sex Hormone Antagonist Introduction
11.13.4 Hinova Pharma Revenue in Sex Hormone Antagonist Business (2018-2023)
11.13.5 Hinova Pharma Recent Developments
11.14 Jiangsu Hengrui Pharmaceuticals
11.14.1 Jiangsu Hengrui Pharmaceuticals Company Details
11.14.2 Jiangsu Hengrui Pharmaceuticals Business Overview
11.14.3 Jiangsu Hengrui Pharmaceuticals Sex Hormone Antagonist Introduction
11.14.4 Jiangsu Hengrui Pharmaceuticals Revenue in Sex Hormone Antagonist Business (2018-2023)
11.14.5 Jiangsu Hengrui Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Sex Hormone Antagonist Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Antiestrogen
Table 3. Key Players of Antiprogestin
Table 4. Key Players of Antiandrogen
Table 5. Global Sex Hormone Antagonist Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 6. Global Sex Hormone Antagonist Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Sex Hormone Antagonist Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Sex Hormone Antagonist Market Share by Region (2018-2023)
Table 9. Global Sex Hormone Antagonist Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Sex Hormone Antagonist Market Share by Region (2024-2033)
Table 11. Sex Hormone Antagonist Market Trends
Table 12. Sex Hormone Antagonist Market Drivers
Table 13. Sex Hormone Antagonist Market Challenges
Table 14. Sex Hormone Antagonist Market Restraints
Table 15. Global Sex Hormone Antagonist Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Sex Hormone Antagonist Revenue Share by Players (2018-2023)
Table 17. Global Top Sex Hormone Antagonist by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sex Hormone Antagonist as of 2022)
Table 18. Global Sex Hormone Antagonist Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Sex Hormone Antagonist Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Sex Hormone Antagonist, Headquarters and Area Served
Table 21. Global Key Players of Sex Hormone Antagonist, Product and Application
Table 22. Global Key Players of Sex Hormone Antagonist, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Sex Hormone Antagonist Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Sex Hormone Antagonist Revenue Market Share by Type (2018-2023)
Table 26. Global Sex Hormone Antagonist Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Sex Hormone Antagonist Revenue Market Share by Type (2024-2033)
Table 28. Global Sex Hormone Antagonist Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Sex Hormone Antagonist Revenue Share by Application (2018-2023)
Table 30. Global Sex Hormone Antagonist Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Sex Hormone Antagonist Revenue Share by Application (2024-2033)
Table 32. North America Sex Hormone Antagonist Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Sex Hormone Antagonist Market Size by Type (2024-2033) & (US$ Million)
Table 34. North America Sex Hormone Antagonist Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Sex Hormone Antagonist Market Size by Application (2024-2033) & (US$ Million)
Table 36. North America Sex Hormone Antagonist Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. North America Sex Hormone Antagonist Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Sex Hormone Antagonist Market Size by Country (2024-2033) & (US$ Million)
Table 39. Europe Sex Hormone Antagonist Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Sex Hormone Antagonist Market Size by Type (2024-2033) & (US$ Million)
Table 41. Europe Sex Hormone Antagonist Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Sex Hormone Antagonist Market Size by Application (2024-2033) & (US$ Million)
Table 43. Europe Sex Hormone Antagonist Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Europe Sex Hormone Antagonist Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Sex Hormone Antagonist Market Size by Country (2024-2033) & (US$ Million)
Table 46. China Sex Hormone Antagonist Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Sex Hormone Antagonist Market Size by Type (2024-2033) & (US$ Million)
Table 48. China Sex Hormone Antagonist Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Sex Hormone Antagonist Market Size by Application (2024-2033) & (US$ Million)
Table 50. Asia Sex Hormone Antagonist Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Sex Hormone Antagonist Market Size by Type (2024-2033) & (US$ Million)
Table 52. Asia Sex Hormone Antagonist Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Sex Hormone Antagonist Market Size by Application (2024-2033) & (US$ Million)
Table 54. Asia Sex Hormone Antagonist Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 55. Asia Sex Hormone Antagonist Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Sex Hormone Antagonist Market Size by Region (2024-2033) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Sex Hormone Antagonist Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Sex Hormone Antagonist Market Size by Type (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Sex Hormone Antagonist Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Sex Hormone Antagonist Market Size by Application (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Sex Hormone Antagonist Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 62. Middle East, Africa, and Latin America Sex Hormone Antagonist Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Sex Hormone Antagonist Market Size by Country (2024-2033) & (US$ Million)
Table 64. Pfizer Company Details
Table 65. Pfizer Business Overview
Table 66. Pfizer Sex Hormone Antagonist Product
Table 67. Pfizer Revenue in Sex Hormone Antagonist Business (2018-2023) & (US$ Million)
Table 68. Pfizer Recent Developments
Table 69. Johnson & Johnson Company Details
Table 70. Johnson & Johnson Business Overview
Table 71. Johnson & Johnson Sex Hormone Antagonist Product
Table 72. Johnson & Johnson Revenue in Sex Hormone Antagonist Business (2018-2023) & (US$ Million)
Table 73. Johnson & Johnson Recent Developments
Table 74. AstraZeneca Company Details
Table 75. AstraZeneca Business Overview
Table 76. AstraZeneca Sex Hormone Antagonist Product
Table 77. AstraZeneca Revenue in Sex Hormone Antagonist Business (2018-2023) & (US$ Million)
Table 78. AstraZeneca Recent Developments
Table 79. Astellas Company Details
Table 80. Astellas Business Overview
Table 81. Astellas Sex Hormone Antagonist Product
Table 82. Astellas Revenue in Sex Hormone Antagonist Business (2018-2023) & (US$ Million)
Table 83. Astellas Recent Developments
Table 84. Merck Company Details
Table 85. Merck Business Overview
Table 86. Merck Sex Hormone Antagonist Product
Table 87. Merck Revenue in Sex Hormone Antagonist Business (2018-2023) & (US$ Million)
Table 88. Merck Recent Developments
Table 89. Sanofi Company Details
Table 90. Sanofi Business Overview
Table 91. Sanofi Sex Hormone Antagonist Product
Table 92. Sanofi Revenue in Sex Hormone Antagonist Business (2018-2023) & (US$ Million)
Table 93. Sanofi Recent Developments
Table 94. Eli Lilly and Company Company Details
Table 95. Eli Lilly and Company Business Overview
Table 96. Eli Lilly and Company Sex Hormone Antagonist Product
Table 97. Eli Lilly and Company Revenue in Sex Hormone Antagonist Business (2018-2023) & (US$ Million)
Table 98. Eli Lilly and Company Recent Developments
Table 99. Kyowa Kirin International Company Details
Table 100. Kyowa Kirin International Business Overview
Table 101. Kyowa Kirin International Sex Hormone Antagonist Product
Table 102. Kyowa Kirin International Revenue in Sex Hormone Antagonist Business (2018-2023) & (US$ Million)
Table 103. Kyowa Kirin International Recent Developments
Table 104. Bayer Company Details
Table 105. Bayer Business Overview
Table 106. Bayer Sex Hormone Antagonist Product
Table 107. Bayer Revenue in Sex Hormone Antagonist Business (2018-2023) & (US$ Million)
Table 108. Bayer Recent Developments
Table 109. Orion Corporation Company Details
Table 110. Orion Corporation Business Overview
Table 111. Orion Corporation Sex Hormone Antagonist Product
Table 112. Orion Corporation Revenue in Sex Hormone Antagonist Business (2018-2023) & (US$ Million)
Table 113. Orion Corporation Recent Developments
Table 114. Hengrui Company Details
Table 115. Hengrui Business Overview
Table 116. Hengrui Sex Hormone Antagonist Product
Table 117. Hengrui Revenue in Sex Hormone Antagonist Business (2018-2023) & (US$ Million)
Table 118. Hengrui Recent Developments
Table 119. Schering-Plough Company Details
Table 120. Schering-Plough Business Overview
Table 121. Schering-Plough Sex Hormone Antagonist Product
Table 122. Schering-Plough Revenue in Sex Hormone Antagonist Business (2018-2023) & (US$ Million)
Table 123. Schering-Plough Recent Developments
Table 124. Hinova Pharma Company Details
Table 125. Hinova Pharma Business Overview
Table 126. Hinova Pharma Sex Hormone Antagonist Product
Table 127. Hinova Pharma Revenue in Sex Hormone Antagonist Business (2018-2023) & (US$ Million)
Table 128. Hinova Pharma Recent Developments
Table 129. Jiangsu Hengrui Pharmaceuticals Company Details
Table 130. Jiangsu Hengrui Pharmaceuticals Business Overview
Table 131. Jiangsu Hengrui Pharmaceuticals Sex Hormone Antagonist Product
Table 132. Jiangsu Hengrui Pharmaceuticals Revenue in Sex Hormone Antagonist Business (2018-2023) & (US$ Million)
Table 133. Jiangsu Hengrui Pharmaceuticals Recent Developments
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sex Hormone Antagonist Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Sex Hormone Antagonist Market Share by Type: 2022 VS 2033
Figure 3. Antiestrogen Features
Figure 4. Antiprogestin Features
Figure 5. Antiandrogen Features
Figure 6. Global Sex Hormone Antagonist Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 7. Global Sex Hormone Antagonist Market Share by Application: 2022 VS 2033
Figure 8. Breast Cancer Case Studies
Figure 9. Prostate Cancer Case Studies
Figure 10. Endometriosis Case Studies
Figure 11. Others Case Studies
Figure 12. Sex Hormone Antagonist Report Years Considered
Figure 13. Global Sex Hormone Antagonist Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Sex Hormone Antagonist Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Sex Hormone Antagonist Market Share by Region: 2022 VS 2033
Figure 16. Global Sex Hormone Antagonist Market Share by Players in 2022
Figure 17. Global Top Sex Hormone Antagonist Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sex Hormone Antagonist as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Sex Hormone Antagonist Revenue in 2022
Figure 19. North America Sex Hormone Antagonist Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Sex Hormone Antagonist Market Share by Type (2018-2033)
Figure 21. North America Sex Hormone Antagonist Market Share by Application (2018-2033)
Figure 22. North America Sex Hormone Antagonist Market Share by Country (2018-2033)
Figure 23. United States Sex Hormone Antagonist Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Sex Hormone Antagonist Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Sex Hormone Antagonist Market Size YoY (2018-2033) & (US$ Million)
Figure 26. Europe Sex Hormone Antagonist Market Share by Type (2018-2033)
Figure 27. Europe Sex Hormone Antagonist Market Share by Application (2018-2033)
Figure 28. Europe Sex Hormone Antagonist Market Share by Country (2018-2033)
Figure 29. Germany Sex Hormone Antagonist Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. France Sex Hormone Antagonist Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. U.K. Sex Hormone Antagonist Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Italy Sex Hormone Antagonist Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Russia Sex Hormone Antagonist Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Nordic Countries Sex Hormone Antagonist Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. China Sex Hormone Antagonist Market Size YoY (2018-2033) & (US$ Million)
Figure 36. China Sex Hormone Antagonist Market Share by Type (2018-2033)
Figure 37. China Sex Hormone Antagonist Market Share by Application (2018-2033)
Figure 38. Asia Sex Hormone Antagonist Market Size YoY (2018-2033) & (US$ Million)
Figure 39. Asia Sex Hormone Antagonist Market Share by Type (2018-2033)
Figure 40. Asia Sex Hormone Antagonist Market Share by Application (2018-2033)
Figure 41. Asia Sex Hormone Antagonist Market Share by Region (2018-2033)
Figure 42. Japan Sex Hormone Antagonist Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. South Korea Sex Hormone Antagonist Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. China Taiwan Sex Hormone Antagonist Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Southeast Asia Sex Hormone Antagonist Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. India Sex Hormone Antagonist Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Australia Sex Hormone Antagonist Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Sex Hormone Antagonist Market Size YoY (2018-2033) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Sex Hormone Antagonist Market Share by Type (2018-2033)
Figure 50. Middle East, Africa, and Latin America Sex Hormone Antagonist Market Share by Application (2018-2033)
Figure 51. Middle East, Africa, and Latin America Sex Hormone Antagonist Market Share by Country (2018-2033)
Figure 52. Brazil Sex Hormone Antagonist Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Mexico Sex Hormone Antagonist Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Turkey Sex Hormone Antagonist Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Saudi Arabia Sex Hormone Antagonist Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Israel Sex Hormone Antagonist Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. GCC Countries Sex Hormone Antagonist Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Pfizer Revenue Growth Rate in Sex Hormone Antagonist Business (2018-2023)
Figure 59. Johnson & Johnson Revenue Growth Rate in Sex Hormone Antagonist Business (2018-2023)
Figure 60. AstraZeneca Revenue Growth Rate in Sex Hormone Antagonist Business (2018-2023)
Figure 61. Astellas Revenue Growth Rate in Sex Hormone Antagonist Business (2018-2023)
Figure 62. Merck Revenue Growth Rate in Sex Hormone Antagonist Business (2018-2023)
Figure 63. Sanofi Revenue Growth Rate in Sex Hormone Antagonist Business (2018-2023)
Figure 64. Eli Lilly and Company Revenue Growth Rate in Sex Hormone Antagonist Business (2018-2023)
Figure 65. Kyowa Kirin International Revenue Growth Rate in Sex Hormone Antagonist Business (2018-2023)
Figure 66. Bayer Revenue Growth Rate in Sex Hormone Antagonist Business (2018-2023)
Figure 67. Orion Corporation Revenue Growth Rate in Sex Hormone Antagonist Business (2018-2023)
Figure 68. Hengrui Revenue Growth Rate in Sex Hormone Antagonist Business (2018-2023)
Figure 69. Schering-Plough Revenue Growth Rate in Sex Hormone Antagonist Business (2018-2023)
Figure 70. Hinova Pharma Revenue Growth Rate in Sex Hormone Antagonist Business (2018-2023)
Figure 71. Jiangsu Hengrui Pharmaceuticals Revenue Growth Rate in Sex Hormone Antagonist Business (2018-2023)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries